Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vertical Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of branded prescription products in niche therapeutic categories. The company's primary areas of focus include women's health, pain management, and neuroscience. Founded in 2003, Vertical built a diverse portfolio through strategic acquisitions and internal development, featuring products such as Divigel for menopause and Lorzone for muscle spasms. In 2016, the company merged with Osmotica Pharmaceutical and Trigen Laboratories to form Osmotica Pharmaceuticals plc. In 2021, the legacy business of Osmotica, including Vertical Pharmaceuticals, was acquired by Alora Pharmaceuticals, where it continues to operate as a subsidiary.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vertical Pharms.